Posted inMedicine
FDA staff outline shortcomings of Lykos data for MDMA therapy
Food and Drug Administration scientists have reservations about a potential new treatment for post-traumatic stress disorder that’s currently up for approval. Developed by an unusual company called Lykos Therapeutics, the…